Doctors and insurers are battling to reshape the controversial No Surprises Act arbitration process, which has long ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also ...

Addiction medicine offers a useful framework. Many people use substances without developing addiction. The difference often ...

Late last month, Utah’s Medical Licensing Board called for the immediate suspension of the state’s pilot program with the AI ...

Casey Ross covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy. Bob Herman covers health insurance, government programs, hospitals, ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

Last year, the FDA had warned that natural opioids in kratom were being turned into harmful products. Now President Trump ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. The scientists whose work ...

European researchers have diagnosed a number of men who have sex with other men with a skin disease that normally infects ...

The WHO held a press conference about the situation Thursday. Here are five key takeaways: At present no one who is ill is ...

Former FDA leaders, the pharmaceutical industry’s main lobbying group, and more than two dozen food and drug law scholars ...